Triptans for migraine
66 results
1 - 66
Triptans for migraine 
Triptans outperform older and newer treatments of acute migraine- Ubrogepant modestly effective for acute migraine, but safety and a lack of comparison with triptans are concerning
- Migraine
- What are the comparative benefits of available treatments for acute migraine pain?
- Rimegepant somewhat effective for acute migraine (NNT = 13)
Drugs for the acute treatment of migraine in children and adolescents- Oral sumatriptan for acute migraine: Cochrane systematic review
- Pharmacological interventions for acute attacks of vestibular migraine
- Triptans for acute cluster headache
- Drugs for the acute treatment of migraine in children and adolescents
- Ubrogepant during migraine prodrome is more effective than placebo to prevent moderate or severe headaches (NNT = 6)
- Maternal triptan use during pregnancy is not associated with risk of attention-deficit/hyperactivity disorder in offspring
- AAN Guidelines on medications for acute treatment and prevention of migraine in children and adolescents
- Clinical practice guideline update for migraine prevention with medications
- Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults
- Rizatriptan for acute migraine: Cochrane systematic review
- Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults
- Sumatriptan (oral route of administration) for acute migraine attacks in adults
- Sumatriptan (rectal route of administration) for acute migraine attacks in adults
- Zolmitriptan for acute migraine attacks in adults
- Sumatriptan (intranasal route of administration) for acute migraine attacks in adults
- Ibuprofen with or without an antiemetic for acute migraine headaches in adults
- Sumatriptan (all routes of administration) for acute migraine attacks in adults ‐ overview of Cochrane reviews
- Aspirin with or without an antiemetic for acute migraine headaches in adults
- Intranasal zavegepant is moderately superior to placebo for acute migraine in adults
- Migraine prevention: Anti-CGRP monoclonal antibodies and onabotulinumtoxinA have similar rates of cardiovascular harm in older adults
- Pharmacological treatment of depression
- Headache in children
- Headache